Annual report
4820.TEDINET S100T65I
Period2023-01-01 → 2023-12-31
Filed2024-03-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 186
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥20.4bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥16.9bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥14.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.7bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.0bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.1bn | 2018-01-01 → 2018-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.3bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥2.4bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.9bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.6bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.2bn | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2018-01-01 → 2018-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.8bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.8bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥29.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥26.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥24.8bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥23.1bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥23.4bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥22.4bn | at 2018-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.8bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥6.8bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.5bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥18.8bn | at 2021-12-31d | Cons. | Net assets |
| Net assets / equity | ¥17.7bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥17.7bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥16.6bn | at 2018-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.4bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.4bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.3bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.0bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥8.8bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥7.5bn | at 2018-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.5bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥442m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.8bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥577m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥544m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥147m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥343m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥894m | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥993m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.3bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥693m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥668m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.0bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥27.76 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.75 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.72 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.95 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.74 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.87 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥27.68 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.66 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.64 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.88 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥19.47 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.46 | 2018-01-01 → 2018-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥289.47 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥274.94 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥263.12 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥248.55 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥247.51 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥234.53 | at 2018-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 69.6% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.4% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.1% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2018-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.8% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.9% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 811 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 592 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 558 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 557 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 575 | at 2019-12-31d | Cons. | Number of employees |
| Employees | 581 | at 2018-12-31d | Cons. | Number of employees |
| Revenue | ¥17.3bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥16.1bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥13.6bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.9bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.3bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.7bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥2.2bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥2.4bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.8bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.5bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.0bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.8bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | ¥1.7bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥2.0bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥2.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥894m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.3bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.8bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥26.4bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥25.2bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥23.9bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥21.6bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥22.1bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥21.3bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.7bn | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥6.3bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥19.7bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥19.0bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥18.2bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥16.8bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥16.9bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥16.0bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.9bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.3bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥24.12 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.79 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.6 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.59 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.44 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.92 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥24.04 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.71 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.51 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥12.53 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.19 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.54 | 2018-01-01 → 2018-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥14 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥11 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2018-01-01 → 2018-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥278.05 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥267.83 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥255.16 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥235.28 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥236.71 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥225.21 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 74.5% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.0% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.1% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.4% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.1% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.8% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 74,514,800 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,514,800 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,514,800 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,514,800 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,063,600 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 36,649,400 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 457 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 432 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 413 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 418 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 448 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 430 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 85
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-12-31 | 37 pure |
| Otherother segments | capex | 2023-01-01 → 2023-12-31 | ¥0 |
| Otherother segments | depreciation | 2023-01-01 → 2023-12-31 | ¥4m |
| Otherother segments | revenue | 2023-01-01 → 2023-12-31 | ¥973m |
| Otherother segments | revenue external | 2023-01-01 → 2023-12-31 | ¥860m |
| Otherother segments | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥112m |
| Otherother segments | segment assets | at 2023-12-31 | ¥876m |
| Otherother segments | segment profit | 2023-01-01 → 2023-12-31 | ¥48m |
| Reconciling Itemsreconciling | capex | 2023-01-01 → 2023-12-31 | −¥20m |
| Reconciling Itemsreconciling | depreciation | 2023-01-01 → 2023-12-31 | ¥200m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-12-31 | −¥131m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-12-31 | −¥131m |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥17.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | ¥13m |
| Care Welfare IT Systems Businessreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥175m |
| Care Welfare IT Systems Businessreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥153m |
| Care Welfare IT Systems Businessreportable segment | employees | at 2023-12-31 | 64 pure |
| Care Welfare IT Systems Businessreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥550m |
| Care Welfare IT Systems Businessreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥550m |
| Care Welfare IT Systems Businessreportable segment | segment assets | at 2023-12-31 | ¥902m |
| Care Welfare IT Systems Businessreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥540m |
| Medecl Computerreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥83m |
| Medecl Computerreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥203m |
| Medecl Computerreportable segment | employees | at 2023-12-31 | 121 pure |
| Medecl Computerreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥2.8bn |
| Medecl Computerreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥2.8bn |
| Medecl Computerreportable segment | segment assets | at 2023-12-31 | ¥1.2bn |
| Medecl Computerreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥130m |
| Pharmacy Receipt Computerreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥3.2bn |
| Pharmacy Receipt Computerreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥687m |
| Pharmacy Receipt Computerreportable segment | employees | at 2023-12-31 | 541 pure |
| Pharmacy Receipt Computerreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥16.2bn |
| Pharmacy Receipt Computerreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥16.1bn |
| Pharmacy Receipt Computerreportable segment | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥18m |
| Pharmacy Receipt Computerreportable segment | segment assets | at 2023-12-31 | ¥9.1bn |
| Pharmacy Receipt Computerreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥2.9bn |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥3.4bn |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥1.0bn |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥20.5bn |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥20.4bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-12-31 | ¥131m |
| —segment total | segment assets | at 2023-12-31 | ¥12.2bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥2.3bn |
| Otherother segments | capex | 2022-01-01 → 2022-12-31 | ¥0 |
| Otherother segments | depreciation | 2022-01-01 → 2022-12-31 | ¥4m |
| Otherother segments | revenue | 2022-01-01 → 2022-12-31 | ¥713m |
| Otherother segments | revenue external | 2022-01-01 → 2022-12-31 | ¥661m |
| Otherother segments | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥51m |
| Otherother segments | segment assets | at 2022-12-31 | ¥729m |
| Otherother segments | segment profit | 2022-01-01 → 2022-12-31 | −¥42m |
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥20m |
| Reconciling Itemsreconciling | depreciation | 2022-01-01 → 2022-12-31 | ¥220m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥66m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-12-31 | −¥66m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥18.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | ¥28m |
| Care Welfare IT Systems Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥241m |
| Care Welfare IT Systems Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥96m |
| Care Welfare IT Systems Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥539m |
| Care Welfare IT Systems Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥539m |
| Care Welfare IT Systems Businessreportable segment | segment assets | at 2022-12-31 | ¥1.0bn |
| Care Welfare IT Systems Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥211m |
| Medecl Computerreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥34m |
| Medecl Computerreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥190m |
| Medecl Computerreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥2.2bn |
| Medecl Computerreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥2.2bn |
| Medecl Computerreportable segment | segment assets | at 2022-12-31 | ¥1.2bn |
| Medecl Computerreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥409m |
| Pharmacy Receipt Computerreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥299m |
| Pharmacy Receipt Computerreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥361m |
| Pharmacy Receipt Computerreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥13.5bn |
| Pharmacy Receipt Computerreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥13.5bn |
| Pharmacy Receipt Computerreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥15m |
| Pharmacy Receipt Computerreportable segment | segment assets | at 2022-12-31 | ¥5.4bn |
| Pharmacy Receipt Computerreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥3.0bn |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥575m |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥652m |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥17.0bn |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥16.9bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥66m |
| —segment total | segment assets | at 2022-12-31 | ¥8.3bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥2.4bn |
| Care Welfare IT Systems Businessreportable segment | employees | at 2023-12-31 | 41 pure |
| Medecl Computerreportable segment | employees | at 2023-12-31 | 78 pure |
| Pharmacy Receipt Computerreportable segment | employees | at 2023-12-31 | 313 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,691
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital stock (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 2785000000 | JPY |
| Capital stock (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 2785000000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 2785000000 | JPY |
| Capital stock (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 2785000000 | JPY |
| Total number of issued shares (5-year summary) | Prior5YearInstant_NonConsolidatedMember | 36649400 | |
| Total number of issued shares (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 74063600 | |
| Total number of issued shares (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 74514800 | |
| Total number of issued shares (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 74514800 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 74514800 | |
| Total number of issued shares (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 74514800 | |
| Net assets (5-year summary) | Prior5YearInstant_NonConsolidatedMember | 15962000000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 16923000000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 16768000000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 18217000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 18977000000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 19712000000 | JPY |
| Total assets (5-year summary) | Prior5YearInstant_NonConsolidatedMember | 21265000000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 22104000000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 21606000000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 23870000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 25230000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 26376000000 | JPY |
| Net assets per share (5-year summary) | Prior5YearInstant_NonConsolidatedMember | 225.21 | |
| Net assets per share (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 236.71 | |
| Net assets per share (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 235.28 | |
| Net assets per share (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 255.16 | |
| Net assets per share (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 267.83 | |
| Net assets per share (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 278.05 | |
| Dividend paid per share (5-year summary) | Prior5YearDuration_NonConsolidatedMember | 19.00 | |
| Dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 14.00 | |
| Dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 10.00 | |
| Dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 11.00 | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 12.00 | |
| Dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 14.00 | |
| Interim dividend paid per share (5-year summary) | Prior5YearDuration_NonConsolidatedMember | 8.00 | |
| Interim dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 8.00 | |
| Interim dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 4.00 | |
| Interim dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 4.00 | |
| Interim dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 4.00 | |
| Interim dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 7.00 | |
| Basic earnings loss per share (5-year summary) | Prior5YearDuration_NonConsolidatedMember | 25.92 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 18.44 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 12.59 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 28.60 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 27.79 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 24.12 | |
| Diluted earnings per share (5-year summary) | Prior5YearDuration_NonConsolidatedMember | 25.54 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 18.19 | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 12.53 | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 28.51 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |